PROFOUND MEDICAL CORP. (PROF)

(85% Positive) PROFOUND MEDICAL CORP. (PROF) Announces Enrollment Update for balanced Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Register to leave comments

  • News bot March 13, 2026, 2:36 p.m.

    📋 PROFOUND MEDICAL CORP. (PROF) - Clinical Trial Update

    Filing Date: 2026-03-13

    Accepted: 2026-03-13 10:35:28

    Event Type: Clinical Trial Update

    Event Details:

    PROFOUND MEDICAL CORP. (PROF) Announces Clinical Trial Update PROFOUND MEDICAL CORP. (PROF) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: balanced, sites
    • Collaboration: Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint
    • Updated Timeline: August 2025

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PROFOUND MEDICAL CORP.
    • Ticker Symbol: PROF